ELI LILLY & Co — Director's Dealing 2014

Aug 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-08-13

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-13	Common Stock	M	8521	$55.65	Acquired	61319	Direct
2014-08-13	Common Stock	F	7789	$60.88	Disposed	53530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-13	Employee stock option 2/05 (right to buy)	$55.65	M	8521	Disposed	2015-02-10	Common Stock (8521.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1578	Indirect
Common Stock	7810	Indirect
Common Stock	1568	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.